Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 19, 2020 - Issue 10
Submit an article Journal homepage
515
Views
4
CrossRef citations to date
0
Altmetric
Review

New and emerging cardiovascular and antihypertensive drugs

Steven G. Chrysanta Department of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USACorrespondence[email protected]
View further author information
&
George S. Chrysantb Department of Cardiology, INTEGRIS Baptist Medical Center, Oklahoma City, OK, USAView further author information
Pages 1315-1327 | Received 15 Jun 2020, Accepted 11 Aug 2020, Published online: 29 Sep 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Steven G. Chrysant. (2021) A novel approach for the treatment of hypertension with the soluble guanylate cyclase stimulating drug. Expert Opinion on Drug Safety 20:6, pages 635-640.
Read now

Articles from other publishers (3)

Windingoudi Rimwagna Christian Ouedraogo, Lazare Belemnaba, Mathieu Nitiema, Boukaré KaboreNoufou Ouedraogo, Moumouni Koala, Rasmané Semde & Sylvin Ouedraogo. (2023) Antioxidant and Vasorelaxant Properties of Phaseolus vulgaris Linn (Fabaceae) Immature Pods Extract on the Thoracic Aorta of NMRI Mice. Biomedical and Pharmacology Journal 16:1, pages 533-548.
Crossref
Annalaura Brai, Claudia Immacolata Trivisani, Chiara Vagaggini, Roberto Stella, Roberto Angeletti, Giulia Iovenitti, Valeria Francardi & Elena Dreassi. (2022) Proteins from Tenebrio molitor: An interesting functional ingredient and a source of ACE inhibitory peptides. Food Chemistry 393, pages 133409.
Crossref
Katharina Brandl, Stephen Schneid & Nora Laiken. (2022) A small‐group activity to enhance learning of cardiovascular drugs for health science students. Pharmacology Research & Perspectives 10:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.